Global and Japan Gastric Motility Disorder Drug Market Insights, Forecast to 2026
Table of Contents1 Study Coverage
1.1 Gastric Motility Disorder Drug Product Introduction
1.2 Market Segments
1.3 Key Gastric Motility Disorder Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Gastric Motility Disorder Drug Market Size Growth Rate by Type
1.4.2 Velusetrag
1.4.3 Ipamorelin
1.4.4 TD-8954
1.4.5 Others
1.5 Market by Application
1.5.1 Global Gastric Motility Disorder Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Home Use
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Gastric Motility Disorder Drug Market Size, Estimates and Forecasts
2.1.1 Global Gastric Motility Disorder Drug Revenue 2015-2026
2.1.2 Global Gastric Motility Disorder Drug Sales 2015-2026
2.2 Global Gastric Motility Disorder Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Gastric Motility Disorder Drug Historical Market Size by Region (2015-2020)
2.3.1 Global Gastric Motility Disorder Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Gastric Motility Disorder Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Gastric Motility Disorder Drug Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Gastric Motility Disorder Drug Sales Forecast by Region (2021-2026)
2.4.2 Global Gastric Motility Disorder Drug Revenue Forecast by Region (2021-2026)
3 Global Gastric Motility Disorder Drug Competitor Landscape by Players
3.1 Global Top Gastric Motility Disorder Drug Sales by Manufacturers
3.1.1 Global Gastric Motility Disorder Drug Sales by Manufacturers (2015-2020)
3.1.2 Global Gastric Motility Disorder Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Global Gastric Motility Disorder Drug Manufacturers by Revenue
3.2.1 Global Gastric Motility Disorder Drug Revenue by Manufacturers (2015-2020)
3.2.2 Global Gastric Motility Disorder Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Gastric Motility Disorder Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Gastric Motility Disorder Drug Revenue in 2019
3.2.5 Global Gastric Motility Disorder Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Gastric Motility Disorder Drug Price by Manufacturers
3.4 Global Gastric Motility Disorder Drug Manufacturing Base Distribution, Product Types
3.4.1 Gastric Motility Disorder Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Gastric Motility Disorder Drug Product Type
3.4.3 Date of International Manufacturers Enter into Gastric Motility Disorder Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Gastric Motility Disorder Drug Market Size by Type (2015-2020)
4.1.1 Global Gastric Motility Disorder Drug Sales by Type (2015-2020)
4.1.2 Global Gastric Motility Disorder Drug Revenue by Type (2015-2020)
4.1.3 Gastric Motility Disorder Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Gastric Motility Disorder Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Gastric Motility Disorder Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Gastric Motility Disorder Drug Revenue Forecast by Type (2021-2026)
4.2.3 Gastric Motility Disorder Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Gastric Motility Disorder Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Gastric Motility Disorder Drug Market Size by Application (2015-2020)
5.1.1 Global Gastric Motility Disorder Drug Sales by Application (2015-2020)
5.1.2 Global Gastric Motility Disorder Drug Revenue by Application (2015-2020)
5.1.3 Gastric Motility Disorder Drug Price by Application (2015-2020)
5.2 Gastric Motility Disorder Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Gastric Motility Disorder Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Gastric Motility Disorder Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Gastric Motility Disorder Drug Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Gastric Motility Disorder Drug Market Size YoY Growth 2015-2026
6.1.1 Japan Gastric Motility Disorder Drug Sales YoY Growth 2015-2026
6.1.2 Japan Gastric Motility Disorder Drug Revenue YoY Growth 2015-2026
6.1.3 Japan Gastric Motility Disorder Drug Market Share in Global Market 2015-2026
6.2 Japan Gastric Motility Disorder Drug Market Size by Players (International and Local Players)
6.2.1 Japan Top Gastric Motility Disorder Drug Players by Sales (2015-2020)
6.2.2 Japan Top Gastric Motility Disorder Drug Players by Revenue (2015-2020)
6.3 Japan Gastric Motility Disorder Drug Historic Market Review by Type (2015-2020)
6.3.1 Japan Gastric Motility Disorder Drug Sales Market Share by Type (2015-2020)
6.3.2 Japan Gastric Motility Disorder Drug Revenue Market Share by Type (2015-2020)
6.3.3 Japan Gastric Motility Disorder Drug Price by Type (2015-2020)
6.4 Japan Gastric Motility Disorder Drug Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Gastric Motility Disorder Drug Sales Forecast by Type (2021-2026)
6.4.2 Japan Gastric Motility Disorder Drug Revenue Forecast by Type (2021-2026)
6.4.3 Japan Gastric Motility Disorder Drug Price Forecast by Type (2021-2026)
6.5 Japan Gastric Motility Disorder Drug Historic Market Review by Application (2015-2020)
6.5.1 Japan Gastric Motility Disorder Drug Sales Market Share by Application (2015-2020)
6.5.2 Japan Gastric Motility Disorder Drug Revenue Market Share by Application (2015-2020)
6.5.3 Japan Gastric Motility Disorder Drug Price by Application (2015-2020)
6.6 Japan Gastric Motility Disorder Drug Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Gastric Motility Disorder Drug Sales Forecast by Application (2021-2026)
6.6.2 Japan Gastric Motility Disorder Drug Revenue Forecast by Application (2021-2026)
6.6.3 Japan Gastric Motility Disorder Drug Price Forecast by Application (2021-2026)
7 North America
7.1 North America Gastric Motility Disorder Drug Market Size YoY Growth 2015-2026
7.2 North America Gastric Motility Disorder Drug Market Facts & Figures by Country
7.2.1 North America Gastric Motility Disorder Drug Sales by Country (2015-2020)
7.2.2 North America Gastric Motility Disorder Drug Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Gastric Motility Disorder Drug Market Size YoY Growth 2015-2026
8.2 Europe Gastric Motility Disorder Drug Market Facts & Figures by Country
8.2.1 Europe Gastric Motility Disorder Drug Sales by Country
8.2.2 Europe Gastric Motility Disorder Drug Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Gastric Motility Disorder Drug Market Size YoY Growth 2015-2026
9.2 Asia Pacific Gastric Motility Disorder Drug Market Facts & Figures by Country
9.2.1 Asia Pacific Gastric Motility Disorder Drug Sales by Region (2015-2020)
9.2.2 Asia Pacific Gastric Motility Disorder Drug Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Gastric Motility Disorder Drug Market Size YoY Growth 2015-2026
10.2 Latin America Gastric Motility Disorder Drug Market Facts & Figures by Country
10.2.1 Latin America Gastric Motility Disorder Drug Sales by Country
10.2.2 Latin America Gastric Motility Disorder Drug Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Gastric Motility Disorder Drug Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Gastric Motility Disorder Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Gastric Motility Disorder Drug Sales by Country
11.2.2 Middle East and Africa Gastric Motility Disorder Drug Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Theravance, Inc.
12.1.1 Theravance, Inc. Corporation Information
12.1.2 Theravance, Inc. Description and Business Overview
12.1.3 Theravance, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Theravance, Inc. Gastric Motility Disorder Drug Products Offered
12.1.5 Theravance, Inc. Recent Development
12.2 Helsinn Healthcare S.A.
12.2.1 Helsinn Healthcare S.A. Corporation Information
12.2.2 Helsinn Healthcare S.A. Description and Business Overview
12.2.3 Helsinn Healthcare S.A. Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Helsinn Healthcare S.A. Gastric Motility Disorder Drug Products Offered
12.2.5 Helsinn Healthcare S.A. Recent Development
12.3 Concert Pharmaceuticals, Inc.
12.3.1 Concert Pharmaceuticals, Inc. Corporation Information
12.3.2 Concert Pharmaceuticals, Inc. Description and Business Overview
12.3.3 Concert Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Products Offered
12.3.5 Concert Pharmaceuticals, Inc. Recent Development
12.4 Targacept, Inc.
12.4.1 Targacept, Inc. Corporation Information
12.4.2 Targacept, Inc. Description and Business Overview
12.4.3 Targacept, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Targacept, Inc. Gastric Motility Disorder Drug Products Offered
12.4.5 Targacept, Inc. Recent Development
12.5 ChironWells GmbH
12.5.1 ChironWells GmbH Corporation Information
12.5.2 ChironWells GmbH Description and Business Overview
12.5.3 ChironWells GmbH Sales, Revenue and Gross Margin (2015-2020)
12.5.4 ChironWells GmbH Gastric Motility Disorder Drug Products Offered
12.5.5 ChironWells GmbH Recent Development
12.11 Theravance, Inc.
12.11.1 Theravance, Inc. Corporation Information
12.11.2 Theravance, Inc. Description and Business Overview
12.11.3 Theravance, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Theravance, Inc. Gastric Motility Disorder Drug Products Offered
12.11.5 Theravance, Inc. Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Gastric Motility Disorder Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Gastric Motility Disorder Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of TablesTable 1. Gastric Motility Disorder Drug Market Segments
Table 2. Ranking of Global Top Gastric Motility Disorder Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Gastric Motility Disorder Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Velusetrag
Table 5. Major Manufacturers of Ipamorelin
Table 6. Major Manufacturers of TD-8954
Table 7. Major Manufacturers of Others
Table 8. Global Gastric Motility Disorder Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global Gastric Motility Disorder Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global Gastric Motility Disorder Drug Sales by Regions 2015-2020 (K Pcs)
Table 11. Global Gastric Motility Disorder Drug Sales Market Share by Regions (2015-2020)
Table 12. Global Gastric Motility Disorder Drug Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Gastric Motility Disorder Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 14. Global Gastric Motility Disorder Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Gastric Motility Disorder Drug Sales Share by Manufacturers (2015-2020)
Table 16. Global Gastric Motility Disorder Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Gastric Motility Disorder Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastric Motility Disorder Drug as of 2019)
Table 18. Gastric Motility Disorder Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Gastric Motility Disorder Drug Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Gastric Motility Disorder Drug Price (2015-2020) (USD/Pcs)
Table 21. Gastric Motility Disorder Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Gastric Motility Disorder Drug Product Type
Table 23. Date of International Manufacturers Enter into Gastric Motility Disorder Drug Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Gastric Motility Disorder Drug Sales by Type (2015-2020) (K Pcs)
Table 26. Global Gastric Motility Disorder Drug Sales Share by Type (2015-2020)
Table 27. Global Gastric Motility Disorder Drug Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Gastric Motility Disorder Drug Revenue Share by Type (2015-2020)
Table 29. Gastric Motility Disorder Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Gastric Motility Disorder Drug Sales Share by Type (2021-2026)
Table 31. Global Gastric Motility Disorder Drug Sales by Application (2015-2020) (K Pcs)
Table 32. Global Gastric Motility Disorder Drug Sales Share by Application (2015-2020)
Table 33. Global Gastric Motility Disorder Drug Sales Share by Application (2021-2026)
Table 34. Global Gastric Motility Disorder Drug Sales Market Share Forecast by Application (2021-2026)
Table 35. Global Gastric Motility Disorder Drug Revenue by Application (2015-2020) (US$ Million)
Table 36. Global Gastric Motility Disorder Drug Revenue Market Share Forecast by Application (2021-2026)
Table 37. Japan Gastric Motility Disorder Drug Sales (K Pcs) of Key Companies (2015-2020)
Table 38. Japan Gastric Motility Disorder Drug Sales Share by Company (2015-2020)
Table 39. Japan Gastric Motility Disorder Drug Revenue (US$ Million) by Company (2015-2020)
Table 40. Japan Gastric Motility Disorder Drug Sales (K Pcs) by Type (2015-2020)
Table 41. Japan Gastric Motility Disorder Drug Sales Share by Type (2015-2020)
Table 42. Japan Gastric Motility Disorder Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 43. Japan Gastric Motility Disorder Drug Price (K Pcs) by Type (2015-2020)
Table 44. Japan Gastric Motility Disorder Drug Sales (K Pcs) by Type (2021-2026)
Table 45. Japan Gastric Motility Disorder Drug Sales Share by Type (2021-2026)
Table 46. Japan Gastric Motility Disorder Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 47. Japan Gastric Motility Disorder Drug Revenue Share by Type (2021-2026)
Table 48. Japan Gastric Motility Disorder Drug Price (K Pcs) by Type (2021-2026)
Table 49. Japan Gastric Motility Disorder Drug Sales (K Pcs) by Application (2015-2020)
Table 50. Japan Gastric Motility Disorder Drug Sales Share by Application (2015-2020)
Table 51. Japan Gastric Motility Disorder Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 52. Japan Gastric Motility Disorder Drug Sales (K Pcs) by Application (2021-2026)
Table 53. Japan Gastric Motility Disorder Drug Sales Share by Application (2021-2026)
Table 54. Japan Gastric Motility Disorder Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 55. Japan Gastric Motility Disorder Drug Revenue Share by Application (2021-2026)
Table 56. North America Gastric Motility Disorder Drug Sales by Country (2015-2020) (K Pcs)
Table 57. North America Gastric Motility Disorder Drug Sales Market Share by Country (2015-2020)
Table 58. North America Gastric Motility Disorder Drug Revenue by Country (2015-2020) (US$ Million)
Table 59. North America Gastric Motility Disorder Drug Revenue Market Share by Country (2015-2020)
Table 60. Europe Gastric Motility Disorder Drug Sales by Country (2015-2020) (K Pcs)
Table 61. Europe Gastric Motility Disorder Drug Sales Market Share by Country (2015-2020)
Table 62. Europe Gastric Motility Disorder Drug Revenue by Country (2015-2020) (US$ Million)
Table 63. Europe Gastric Motility Disorder Drug Revenue Market Share by Country (2015-2020)
Table 64. Asia Pacific Gastric Motility Disorder Drug Sales by Region (2015-2020) (K Pcs)
Table 65. Asia Pacific Gastric Motility Disorder Drug Sales Market Share by Region (2015-2020)
Table 66. Asia Pacific Gastric Motility Disorder Drug Revenue by Region (2015-2020) (US$ Million)
Table 67. Asia Pacific Gastric Motility Disorder Drug Revenue Market Share by Region (2015-2020)
Table 68. Latin America Gastric Motility Disorder Drug Sales by Country (2015-2020) (K Pcs)
Table 69. Latin America Gastric Motility Disorder Drug Sales Market Share by Country (2015-2020)
Table 70. Latin Americaa Gastric Motility Disorder Drug Revenue by Country (2015-2020) (US$ Million)
Table 71. Latin America Gastric Motility Disorder Drug Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Gastric Motility Disorder Drug Sales by Country (2015-2020) (K Pcs)
Table 73. Middle East and Africa Gastric Motility Disorder Drug Sales Market Share by Country (2015-2020)
Table 74. Middle East and Africa Gastric Motility Disorder Drug Revenue by Country (2015-2020) (US$ Million)
Table 75. Middle East and Africa Gastric Motility Disorder Drug Revenue Market Share by Country (2015-2020)
Table 76. Theravance, Inc. Corporation Information
Table 77. Theravance, Inc. Description and Business Overview
Table 78. Theravance, Inc. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. Theravance, Inc. Gastric Motility Disorder Drug Product
Table 80. Theravance, Inc. Recent Development
Table 81. Helsinn Healthcare S.A. Corporation Information
Table 82. Helsinn Healthcare S.A. Description and Business Overview
Table 83. Helsinn Healthcare S.A. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. Helsinn Healthcare S.A. Product
Table 85. Helsinn Healthcare S.A. Recent Development
Table 86. Concert Pharmaceuticals, Inc. Corporation Information
Table 87. Concert Pharmaceuticals, Inc. Description and Business Overview
Table 88. Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. Concert Pharmaceuticals, Inc. Product
Table 90. Concert Pharmaceuticals, Inc. Recent Development
Table 91. Targacept, Inc. Corporation Information
Table 92. Targacept, Inc. Description and Business Overview
Table 93. Targacept, Inc. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. Targacept, Inc. Product
Table 95. Targacept, Inc. Recent Development
Table 96. ChironWells GmbH Corporation Information
Table 97. ChironWells GmbH Description and Business Overview
Table 98. ChironWells GmbH Gastric Motility Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 99. ChironWells GmbH Product
Table 100. ChironWells GmbH Recent Development
Table 101. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 102. Key Challenges
Table 103. Market Risks
Table 104. Main Points Interviewed from Key Gastric Motility Disorder Drug Players
Table 105. Gastric Motility Disorder Drug Customers List
Table 106. Gastric Motility Disorder Drug Distributors List
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of FiguresFigure 1. Gastric Motility Disorder Drug Product Picture
Figure 2. Global Gastric Motility Disorder Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Velusetrag Product Picture
Figure 4. Ipamorelin Product Picture
Figure 5. TD-8954 Product Picture
Figure 6. Others Product Picture
Figure 7. Global Gastric Motility Disorder Drug Sales Market Share by Application in 2020 & 2026
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Home Use
Figure 11. Gastric Motility Disorder Drug Report Years Considered
Figure 12. Global Gastric Motility Disorder Drug Market Size 2015-2026 (US$ Million)
Figure 13. Global Gastric Motility Disorder Drug Sales 2015-2026 (K Pcs)
Figure 14. Global Gastric Motility Disorder Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Gastric Motility Disorder Drug Sales Market Share by Region (2015-2020)
Figure 16. Global Gastric Motility Disorder Drug Sales Market Share by Region in 2019
Figure 17. Global Gastric Motility Disorder Drug Revenue Market Share by Region (2015-2020)
Figure 18. Global Gastric Motility Disorder Drug Revenue Market Share by Region in 2019
Figure 19. Global Gastric Motility Disorder Drug Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Gastric Motility Disorder Drug Revenue in 2019
Figure 21. Gastric Motility Disorder Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Gastric Motility Disorder Drug Sales Market Share by Type (2015-2020)
Figure 23. Global Gastric Motility Disorder Drug Sales Market Share by Type in 2019
Figure 24. Global Gastric Motility Disorder Drug Revenue Market Share by Type (2015-2020)
Figure 25. Global Gastric Motility Disorder Drug Revenue Market Share by Type in 2019
Figure 26. Global Gastric Motility Disorder Drug Market Share by Price Range (2015-2020)
Figure 27. Global Gastric Motility Disorder Drug Sales Market Share by Application (2015-2020)
Figure 28. Global Gastric Motility Disorder Drug Sales Market Share by Application in 2019
Figure 29. Global Gastric Motility Disorder Drug Revenue Market Share by Application (2015-2020)
Figure 30. Global Gastric Motility Disorder Drug Revenue Market Share by Application in 2019
Figure 31. Japan Gastric Motility Disorder Drug Sales Growth Rate 2015-2026 (K Pcs)
Figure 32. Japan Gastric Motility Disorder Drug Revenue Growth Rate 2015-2026 (US$ Million)
Figure 33. Japan Gastric Motility Disorder Drug Market Share in Global Market 2015-2026
Figure 34. Japan 5 and 10 Largest Gastric Motility Disorder Drug Players Market Share by Revenue in Gastric Motility Disorder Drug in 2019
Figure 35. Japan Gastric Motility Disorder Drug Revenue Share by Type (2015-2020)
Figure 36. Japan Gastric Motility Disorder Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 37. Japan Gastric Motility Disorder Drug Revenue Share by Application (2015-2020)
Figure 38. Japan Gastric Motility Disorder Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 39. North America Gastric Motility Disorder Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 40. North America Gastric Motility Disorder Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. North America Gastric Motility Disorder Drug Sales Market Share by Country in 2019
Figure 42. North America Gastric Motility Disorder Drug Revenue Market Share by Country in 2019
Figure 43. U.S. Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 44. U.S. Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Canada Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. Canada Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Europe Gastric Motility Disorder Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 48. Europe Gastric Motility Disorder Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 49. Europe Gastric Motility Disorder Drug Sales Market Share by Country in 2019
Figure 50. Europe Gastric Motility Disorder Drug Revenue Market Share by Country in 2019
Figure 51. Germany Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Germany Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. France Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. France Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. U.K. Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. U.K. Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Italy Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 58. Italy Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Russia Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 60. Russia Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Asia Pacific Gastric Motility Disorder Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 62. Asia Pacific Gastric Motility Disorder Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific Gastric Motility Disorder Drug Sales Market Share by Region in 2019
Figure 64. Asia Pacific Gastric Motility Disorder Drug Revenue Market Share by Region in 2019
Figure 65. China Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. China Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. South Korea Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. India Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Australia Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Taiwan Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Indonesia Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Thailand Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Malaysia Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Philippines Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 86. Vietnam Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Latin America Gastric Motility Disorder Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Gastric Motility Disorder Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Gastric Motility Disorder Drug Sales Market Share by Country in 2019
Figure 90. Latin America Gastric Motility Disorder Drug Revenue Market Share by Country in 2019
Figure 91. Mexico Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Middle East and Africa Gastric Motility Disorder Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 98. Middle East and Africa Gastric Motility Disorder Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Gastric Motility Disorder Drug Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Gastric Motility Disorder Drug Revenue Market Share by Country in 2019
Figure 101. Turkey Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Turkey Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Saudi Arabia Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. U.A.E Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Porter's Five Forces Analysis
Figure 108. Gastric Motility Disorder Drug Value Chain
Figure 109. Channels of Distribution
Figure 110. Distributors Profiles
Figure 111. Bottom-up and Top-down Approaches for This Report
Figure 112. Data Triangulation
Figure 113. Key Executives Interviewed